Eu Yan Sang International

Eu Yan Sang International is a company listed under the stock ticker EUYNF (SG).

Eu Yan Sang International has a direct presence in 3 countries.

View the org chart displaying its 20 main executives

Most searched biographies at Eu Yan Sang International

• Dominic Wong, Chief Executive Officer
• Richard Eu, Chairman of the Board
• Jeffrey Chua, Director

Create your alert
to follow the executive moves at Eu Yan Sang International.

Eu Yan Sang International has 1,868 competitors including Pfizer (United States (USA)), Sanofi (France) and Johnson & Johnson (United States (USA)).

Popular M&A news in Pharmaceuticals

• AstraZeneca has announced the acquisition of Fusion Pharma  (posted on March 23 2024).
• AstraZeneca has announced the acquisition of Amolyt Pharma  (posted on March 19 2024).
• Frontier Medicines has just announced a $80 Million fundraising (posted on February 27 2024).

Popular contacts in Pharmaceuticals

• Jean-Frédéric Paulsen - Executive Chairman of the Board at Ferring Pharmaceuticals
• Alice Schardt-Rossmann - Managing Director at Dirk Rossmann
• Thierry Abribat - Chief Executive Officer at Amolyt Pharma

Learn more about the Pharmaceuticals industry >

Press releases by Eu Yan Sang International

• Eu Yan Sang International - Official Online Store
• Eu Yan Sang Press Release - Eu Yan Sang International

Social media about Eu Yan Sang International

• Eu Yan Sang International on Wikipedia, Google News & Yahoo Finance
• Eu Yan Sang International on LinkedIn, Twitter & YouTube

Contact by email its executives including Lip Gee Ng

Call Eu Yan Sang International at +65 ...

View the org chart

Register to receive your alert

Report an error